Report Detail

Other Global Oral Antidiabetic Agents Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3624854
  • |
  • 26 July, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.

Scope of the Report:
The global Oral Antidiabetic Agents market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oral Antidiabetic Agents.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Oral Antidiabetic Agents market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oral Antidiabetic Agents market by product type and applications/end industries.

Market Segment by Companies, this report covers
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors

Market Segment by Applications, can be divided into
Home Use
Medical Institutions
Others


Table of Contents

    1 Oral Antidiabetic Agents Market Overview

    • 1.1 Product Overview and Scope of Oral Antidiabetic Agents
    • 1.2 Classification of Oral Antidiabetic Agents by Types
      • 1.2.1 Global Oral Antidiabetic Agents Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Oral Antidiabetic Agents Revenue Market Share by Types in 2018
      • 1.2.3 Sulfonylureas
      • 1.2.4 Meglitinides
      • 1.2.5 Biguanides
      • 1.2.6 Thiazolidinediones
      • 1.2.7 Alpha-glucosidase Inhibitors
    • 1.3 Global Oral Antidiabetic Agents Market by Application
      • 1.3.1 Global Oral Antidiabetic Agents Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Home Use
      • 1.3.3 Medical Institutions
      • 1.3.4 Others
    • 1.4 Global Oral Antidiabetic Agents Market by Regions
      • 1.4.1 Global Oral Antidiabetic Agents Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Oral Antidiabetic Agents Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Oral Antidiabetic Agents Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oral Antidiabetic Agents Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Oral Antidiabetic Agents Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oral Antidiabetic Agents Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Oral Antidiabetic Agents (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Novo Nordisk
      • 2.1.1 Business Overview
      • 2.1.2 Oral Antidiabetic Agents Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Novo Nordisk Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Eli Lilly
      • 2.2.1 Business Overview
      • 2.2.2 Oral Antidiabetic Agents Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Eli Lilly Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Sanofi
      • 2.3.1 Business Overview
      • 2.3.2 Oral Antidiabetic Agents Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Sanofi Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Roche
      • 2.4.1 Business Overview
      • 2.4.2 Oral Antidiabetic Agents Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Roche Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Teva
      • 2.5.1 Business Overview
      • 2.5.2 Oral Antidiabetic Agents Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Teva Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 AstraZeneca
      • 2.6.1 Business Overview
      • 2.6.2 Oral Antidiabetic Agents Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 AstraZeneca Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Wockhardt UK
      • 2.7.1 Business Overview
      • 2.7.2 Oral Antidiabetic Agents Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Wockhardt UK Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Merck
      • 2.8.1 Business Overview
      • 2.8.2 Oral Antidiabetic Agents Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Merck Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Pfizer
      • 2.9.1 Business Overview
      • 2.9.2 Oral Antidiabetic Agents Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Pfizer Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Cipla
      • 2.10.1 Business Overview
      • 2.10.2 Oral Antidiabetic Agents Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Cipla Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Oral Antidiabetic Agents Market Competition, by Players

    • 3.1 Global Oral Antidiabetic Agents Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Oral Antidiabetic Agents Players Market Share
      • 3.2.2 Top 10 Oral Antidiabetic Agents Players Market Share
    • 3.3 Market Competition Trend

    4 Global Oral Antidiabetic Agents Market Size by Regions

    • 4.1 Global Oral Antidiabetic Agents Revenue and Market Share by Regions
    • 4.2 North America Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 4.5 South America Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)

    5 North America Oral Antidiabetic Agents Revenue by Countries

    • 5.1 North America Oral Antidiabetic Agents Revenue by Countries (2014-2019)
    • 5.2 USA Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)

    6 Europe Oral Antidiabetic Agents Revenue by Countries

    • 6.1 Europe Oral Antidiabetic Agents Revenue by Countries (2014-2019)
    • 6.2 Germany Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 6.3 UK Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 6.4 France Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Oral Antidiabetic Agents Revenue by Countries

    • 7.1 Asia-Pacific Oral Antidiabetic Agents Revenue by Countries (2014-2019)
    • 7.2 China Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 7.5 India Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)

    8 South America Oral Antidiabetic Agents Revenue by Countries

    • 8.1 South America Oral Antidiabetic Agents Revenue by Countries (2014-2019)
    • 8.2 Brazil Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Oral Antidiabetic Agents by Countries

    • 9.1 Middle East and Africa Oral Antidiabetic Agents Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Oral Antidiabetic Agents Revenue and Growth Rate (2014-2019)

    10 Global Oral Antidiabetic Agents Market Segment by Type

    • 10.1 Global Oral Antidiabetic Agents Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Oral Antidiabetic Agents Market Forecast by Type (2019-2024)
    • 10.3 Sulfonylureas Revenue Growth Rate (2014-2024)
    • 10.4 Meglitinides Revenue Growth Rate (2014-2024)
    • 10.5 Biguanides Revenue Growth Rate (2014-2024)
    • 10.6 Thiazolidinediones Revenue Growth Rate (2014-2024)
    • 10.7 Alpha-glucosidase Inhibitors Revenue Growth Rate (2014-2024)

    11 Global Oral Antidiabetic Agents Market Segment by Application

    • 11.1 Global Oral Antidiabetic Agents Revenue Market Share by Application (2014-2019)
    • 11.2 Oral Antidiabetic Agents Market Forecast by Application (2019-2024)
    • 11.3 Home Use Revenue Growth (2014-2019)
    • 11.4 Medical Institutions Revenue Growth (2014-2019)
    • 11.5 Others Revenue Growth (2014-2019)

    12 Global Oral Antidiabetic Agents Market Size Forecast (2019-2024)

    • 12.1 Global Oral Antidiabetic Agents Market Size Forecast (2019-2024)
    • 12.2 Global Oral Antidiabetic Agents Market Forecast by Regions (2019-2024)
    • 12.3 North America Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
    • 12.4 Europe Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
    • 12.6 South America Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Oral Antidiabetic Agents Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Oral Antidiabetic Agents. Industry analysis & Market Report on Oral Antidiabetic Agents is a syndicated market report, published as Global Oral Antidiabetic Agents Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Oral Antidiabetic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,752.68
      4,129.02
      5,505.36
      3,208.56
      4,812.84
      6,417.12
      540,444.00
      810,666.00
      1,080,888.00
      290,580.00
      435,870.00
      581,160.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report